Loading...

RVMD REVOLUTION MEDICINES INC Product Launches 8-K Filing

RVLT

RVMD

REVOLUTION MEDICINES INC

(RVMD)

2023 8-K

Show Summary

Show Summary

Strategic Alliances

Financial Statements

Financial Results

Pipeline Updates

Financial Results

Clinical Trial Update

Pipeline Update

Financial Results and Board...

Pipeline Updates and Financ...

Annual Meeting of Stockholders

Financial Results Announcement

Financial Results Announcement

Amendment to 8-K

Acquisition of EQRx, Inc.

Financial Results Announcement

Merger of Equals

Pipeline Updates

Pipeline Updates

Financial Results Announcement

Merger Agreement

Annual Meeting of Stockholders

Financial Results Announcement

Underwriting Agreement

Financial Results Announcement

Results of Operations and F...

External Links:

Revolution Medicines, Inc. provided pipeline updates on their RMC-6236 drug, reporting preliminary safety and anti-tumor data for patients with non-small cell lung cancer and pancreatic ductal adenocarcinoma.

AI Assistant

REVOLUTION MEDICINES INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.